Authors:
GRIESE EU
ZANGER UM
BRUDERMANNS U
GAEDIGK A
MIKUS G
MORIKE K
STUVEN T
EICHELBAUM M
Citation: Eu. Griese et al., ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION, Pharmacogenetics, 8(1), 1998, pp. 15-26
Authors:
GROZINGER M
HARTTER S
HIEMKE C
GRIESE EU
ROSCHKE J
Citation: M. Grozinger et al., INTERACTION OF MODAFINIL AND CLOMIPRAMINE AS COMEDICATION IN A NARCOLEPTIC PATIENT, Clinical neuropharmacology, 21(2), 1998, pp. 127-129
Authors:
LAEPPLE F
GRIESE EU
ZANGER U
THON KP
EICHELBAUM M
Citation: F. Laepple et al., ANALYSIS OF CYP2C8, CYP2C9, CYP2C18 AND CYP2C19 MESSENGER-RNA EXPRESSION IN HUMAN LIVER, SMALL-INTESTINE, SKIN AND LEUKOCYTES, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 74-74
Authors:
GRIESE EU
GAEDIGK A",MORIKE,"MIKUS G
ZANGER U
EICHELBAUM M
Citation: Eu. Griese et al., CATALYTIC IN-VIVO FUNCTION OF CYP2D6 IN RELATION TO THE GENOTYPE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 458-458
Authors:
STUVEN T
GRIESE EU
KROEMER HK
EICHELBAUM M
ZANGER UM
Citation: T. Stuven et al., RAPID DETECTION OF CYP2D6 NULL ALLELES BY LONG DISTANCE-POLYMERASE AND MULTIPLEX-POLYMERASE CHAIN-REACTION, Pharmacogenetics, 6(5), 1996, pp. 417-421
Authors:
KIVISTO KT
BOOKJANS G
FROMM MF
GRIESE EU
MUNZEL P
KROEMER HK
Citation: Kt. Kivisto et al., EXPRESSION OF CYP3A4, CYP3A5 AND CYP3A7 IN HUMAN DUODENAL TISSUE, British journal of clinical pharmacology, 42(3), 1996, pp. 387-389
Authors:
KIVISTO KT
GRIESE EU
FRITZ P
LINDER A
HAKKOLA J
RAUNIO H
BEAUNE P
KROEMER HK
Citation: Kt. Kivisto et al., EXPRESSION OF CYTOCHROME-P-450 3A ENZYMES IN HUMAN LUNG - A COMBINED RT-PCR AND IMMUNOHISTOCHEMICAL ANALYSIS OF NORMAL TISSUE AND LUNG-TUMORS, Naunyn-Schmiedeberg's archives of pharmacology, 353(2), 1996, pp. 207-212
Authors:
MORIKE K
MAGADUM S
METTANG T
GRIESE EU
MACHLEIDT C
KUHLMANN U
Citation: K. Morike et al., PROPAFENONE IN A USUAL DOSE PRODUCES SEVERE SIDE-EFFECTS - THE IMPACTOF GENETICALLY-DETERMINED METABOLIC STATUS ON DRUG-THERAPY, Journal of internal medicine, 238(5), 1995, pp. 469-472
Citation: Mf. Fromm et al., DIHYDROCODEINE - A NEW OPIOID SUBSTRATE FOR THE POLYMORPHIC CYP2D6 INHUMANS, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 374-382
Citation: B. Evert et al., CLONING AND SEQUENCING OF A NEW NONFUNCTIONAL CYP2D6 ALLELE - DELETION OF T-1795 IN EXON-3 GENERATES A PREMATURE STOP CODON, Pharmacogenetics, 4(5), 1994, pp. 271-274
Authors:
BOCK KW
SCHRENK D
FORSTER A
GRIESE EU
MORIKE K
BROCKMEIER D
EICHELBAUM M
Citation: Kw. Bock et al., THE INFLUENCE OF ENVIRONMENTAL AND GENETIC-FACTORS ON CYP2D6, CYP1A2 AND UDP-GLUCURONOSYLTRANSFERASES IN MAN USING SPARTEINE, CAFFEINE, ANDPARACETAMOL AS PROBES, Pharmacogenetics, 4(4), 1994, pp. 209-218
Citation: F. Grunebach et al., COMPETITIVE NESTED POLYMERASE CHAIN-REACTION FOR QUANTIFICATION OF HUMAN MDR1 GENE-EXPRESSION, Journal of cancer research and clinical oncology, 120(9), 1994, pp. 539-544
Citation: B. Evert et al., A MISSENSE MUTATION IN EXON-6 OF THE CYP2D6 GENE LEADING TO A HISTIDINE-324 TO PROLINE EXCHANGE IS ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE OF SPARTEINE, Naunyn-Schmiedeberg's archives of pharmacology, 350(4), 1994, pp. 434-439
Authors:
ARIAS TD
JORGE LF
GRIESE EU
INABA T
EICHELBAUM M
Citation: Td. Arias et al., POLYMORPHIC N-ACETYLTRANSFERASE (NAT2) IN AMERINDIAN POPULATIONS OF PANAMA AND COLOMBIA - HIGH-FREQUENCIES OF POINT MUTATION 857A, AS FOUNDIN ALLELE S3 M3, Pharmacogenetics, 3(6), 1993, pp. 328-331